Elin Jerremalm

Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds

Anne-Barbara Witte, Karin Anestål, Elin Jerremalm et al. · Free Radical Biology and Medicine · 2005 · 223 citations

Reductive Stress, Medicinal Chemistry, Biochemistry +10

Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity

Victoria Hellberg, Inger Wallin, Sven V. Eriksson et al. · JNCI Journal of the National Cancer Institute · 2008 · 108 citations · Full text

Oxaliplatin Degradation in the Presence of Chloride: Identification and Cytotoxicity of the Monochloro Monooxalato Complex

Elin Jerremalm, Mikael Hedeland, Inger Wallin et al. · Pharmaceutical Research · 2004 · 80 citations

Monochloro Monooxalato Complex, Bioorganic Chemistry, Biochemistry +8

Alkaline Hydrolysis of Oxaliplatin—Isolation and Identification of the Oxalato Monodentate Intermediate

Elin Jerremalm, Pernilla Videhult Pierre, Gunvor Alvélius et al. · Journal of Pharmaceutical Sciences · 2002 · 64 citations

Biosynthesis, Aldo-keto Reductase, Biochemistry +6

Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate

Elin Jerremalm, Inger Wallin, Jeffrey Yachnin et al. · European Journal of Pharmaceutical Sciences · 2006 · 36 citations

Plasma Ultrafiltrate, Bioorganic Chemistry, Biochemistry +9